
Rolla Jr.
Examiner (ID: 19028)
| Most Active Art Unit | 3101 |
| Art Unit(s) | 2101, 3101 |
| Total Applications | 283 |
| Issued Applications | 248 |
| Pending Applications | 0 |
| Abandoned Applications | 35 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18538750
[patent_doc_number] => 20230243856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => IDENTIFYING DIRECT ORAL FACTOR XA INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/098422
[patent_app_country] => US
[patent_app_date] => 2023-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4249
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18098422
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/098422 | IDENTIFYING DIRECT ORAL FACTOR XA INHIBITORS | Jan 17, 2023 | Pending |
Array
(
[id] => 18597534
[patent_doc_number] => 20230272330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => EVALUATION SYSTEM AND EVALUATION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/081147
[patent_app_country] => US
[patent_app_date] => 2022-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18081147
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/081147 | EVALUATION SYSTEM AND EVALUATION METHOD | Dec 13, 2022 | Pending |
Array
(
[id] => 18325362
[patent_doc_number] => 20230123490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => COMPOSITIONS COMPRISING YEAST CELLS AND POLYPHENOLS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/062612
[patent_app_country] => US
[patent_app_date] => 2022-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8645
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062612
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062612 | COMPOSITIONS COMPRISING YEAST CELLS AND POLYPHENOLS AND THEIR USE | Dec 6, 2022 | Abandoned |
Array
(
[id] => 18271920
[patent_doc_number] => 20230093162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => FATTY LIVER AND LIVER FIBROSIS EVALUATION SYSTEM BASED ON IMPEDANCE
[patent_app_type] => utility
[patent_app_number] => 18/070401
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070401
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/070401 | FATTY LIVER AND LIVER FIBROSIS EVALUATION SYSTEM BASED ON IMPEDANCE | Nov 27, 2022 | Pending |
Array
(
[id] => 19643222
[patent_doc_number] => 20240417742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => METHOD FOR CULTURING MICROORGANISM, TRANSFORMED MICROORGANISM, AND METHOD FOR PRODUCING POLY(3-HYDROXYALKANOATE)
[patent_app_type] => utility
[patent_app_number] => 18/695099
[patent_app_country] => US
[patent_app_date] => 2022-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18695099
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/695099 | METHOD FOR CULTURING MICROORGANISM, TRANSFORMED MICROORGANISM, AND METHOD FOR PRODUCING POLY(3-HYDROXYALKANOATE) | Sep 27, 2022 | Pending |
Array
(
[id] => 20362777
[patent_doc_number] => 20250352589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-20
[patent_title] => OXYTOCIN-MIMETIC COMPOSITIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/726256
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18726256
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/726256 | OXYTOCIN-MIMETIC COMPOSITIONS AND USES THEREOF | Sep 15, 2022 | Pending |
Array
(
[id] => 17898412
[patent_doc_number] => 20220308074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => QUANTIFICATION METHOD OF VITAMIN D DERIVATIVE, ENZYME FOR QUANTIFICATION, COMPOSITION FOR QUANTIFICATION, KIT FOR QUANTIFICATION, ELECTRODE, SENSOR CHIP, AND SENSOR
[patent_app_type] => utility
[patent_app_number] => 17/837142
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17837142
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/837142 | QUANTIFICATION METHOD OF VITAMIN D DERIVATIVE, ENZYME FOR QUANTIFICATION, COMPOSITION FOR QUANTIFICATION, KIT FOR QUANTIFICATION, ELECTRODE, SENSOR CHIP, AND SENSOR | Jun 9, 2022 | Pending |
Array
(
[id] => 19629735
[patent_doc_number] => 20240408184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => COMPOSITION COMPRISING BOTULINUM-DERIVED PEPTIDE FOR PAIN RELIEF
[patent_app_type] => utility
[patent_app_number] => 18/704129
[patent_app_country] => US
[patent_app_date] => 2022-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18704129
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/704129 | COMPOSITION COMPRISING BOTULINUM-DERIVED PEPTIDE FOR PAIN RELIEF | Jun 1, 2022 | Pending |
Array
(
[id] => 17836423
[patent_doc_number] => 20220273728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => TREATING MYELIN DISEASES WITH OPTIMIZED CELL PREPARATIONS
[patent_app_type] => utility
[patent_app_number] => 17/740126
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740126
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/740126 | Treating myelin diseases with optimized cell preparations | May 8, 2022 | Issued |
Array
(
[id] => 18033836
[patent_doc_number] => 20220378051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => BACTERIOPHAGE COCKTAIL FOR CONTROL OF SALMONELLA AND ESCHERICHIA COLI
[patent_app_type] => utility
[patent_app_number] => 17/719084
[patent_app_country] => US
[patent_app_date] => 2022-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719084
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/719084 | BACTERIOPHAGE COCKTAIL FOR CONTROL OF SALMONELLA AND ESCHERICHIA COLI | Apr 11, 2022 | Abandoned |
Array
(
[id] => 17670109
[patent_doc_number] => 20220183276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => CRYOPRESERVING UNGULATE EMBRYOS
[patent_app_type] => utility
[patent_app_number] => 17/685189
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12226
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17685189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/685189 | Cryopreserving ungulate embryos | Mar 1, 2022 | Issued |
Array
(
[id] => 17733309
[patent_doc_number] => 20220218768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => METHODS OF ENHANCING THE POTENCY OF INCRETIN-BASED DRUGS IN SUBJECTS IN NEED THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/673083
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673083
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673083 | METHODS OF ENHANCING THE POTENCY OF INCRETIN-BASED DRUGS IN SUBJECTS IN NEED THEREOF | Feb 15, 2022 | Abandoned |
Array
(
[id] => 18956594
[patent_doc_number] => 20240044921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => METHOD FOR EVALUATING BLOOD COAGULATION PERFORMANCE, AND METHOD FOR INSPECTING RISK OF THROMBOSIS
[patent_app_type] => utility
[patent_app_number] => 18/269860
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269860
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269860 | METHOD FOR EVALUATING BLOOD COAGULATION PERFORMANCE, AND METHOD FOR INSPECTING RISK OF THROMBOSIS | Dec 27, 2021 | Pending |
Array
(
[id] => 17702872
[patent_doc_number] => 20220202878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => COMPOSITION FOR PREVENTION OR TREATMENT OF NEURODEVELOPMENTAL DISORDER, NEUROLOGIC DISEASES, OR PSYCHIATRIC DISEASES COMPRISING EXTRACELLULAR VESICLES DERIVED FROM MICROCOCCUS LUTEUS
[patent_app_type] => utility
[patent_app_number] => 17/646143
[patent_app_country] => US
[patent_app_date] => 2021-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17646143
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/646143 | Composition for prevention or treatment of neurodevelopmental disorder, neurologic diseases, or psychiatric diseases comprising extracellular vesicles derived from | Dec 26, 2021 | Issued |
Array
(
[id] => 17480589
[patent_doc_number] => 20220088093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => Novel Lactobacillus Having Various Functions, and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/455328
[patent_app_country] => US
[patent_app_date] => 2021-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17455328
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/455328 | None | Nov 16, 2021 | Issued |
Array
(
[id] => 18860273
[patent_doc_number] => 20230414707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => CONTROL OF MICROORGANISMS IN MICROBIAL COMMUNITIES
[patent_app_type] => utility
[patent_app_number] => 18/252030
[patent_app_country] => US
[patent_app_date] => 2021-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252030
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/252030 | CONTROL OF MICROORGANISMS IN MICROBIAL COMMUNITIES | Nov 4, 2021 | Pending |
Array
(
[id] => 17563417
[patent_doc_number] => 20220127566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => Sexed Sperm Bulk Separation Systems
[patent_app_type] => utility
[patent_app_number] => 17/480402
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480402
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480402 | Sexed Sperm Bulk Separation Systems | Sep 20, 2021 | Pending |
Array
(
[id] => 17336372
[patent_doc_number] => 20220002703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => ADAMTS13-CONTAINING COMPOSITIONS HAVING THROMBOLYTIC ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/478520
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/478520 | ADAMTS13-CONTAINING COMPOSITIONS HAVING THROMBOLYTIC ACTIVITY | Sep 16, 2021 | Abandoned |
Array
(
[id] => 17297865
[patent_doc_number] => 20210393704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/466516
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17466516
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/466516 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | Sep 2, 2021 | Pending |
Array
(
[id] => 18740912
[patent_doc_number] => 20230349890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => METHOD FOR DETERMINATION OF BASOPHIL ACTIVATION AND KITS THEREFORE
[patent_app_type] => utility
[patent_app_number] => 18/041606
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041606
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041606 | METHOD FOR DETERMINATION OF BASOPHIL ACTIVATION AND KITS THEREFORE | Aug 18, 2021 | Pending |